RARECHEM AL BF 1110
|
- $55 - $851
- Product name: RARECHEM AL BF 1110
- CAS: 39665-58-2
- MF: C17H20O2
- MW: 256.34
- EINECS:
- MDL Number:MFCD06204039
- Synonyms:RARECHEM AL BF 1110;Methyl 5-isopropyl-3,8-dimethylazulene-1-carboxylate;Methyl guaiazulene-3-carboxylate;1-Azulenecarboxylic acid, 3,8-dimethyl-5-(1-methylethyl)-, methyl ester
4 prices
Selected condition：
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Crysdot
- TRC
Package
- 5MG
- 250mg
- 100g
- ManufacturerAK Scientific
- Product number5214AB
- Product descriptionMethyl5-isopropyl-3,8-dimethylazulene-1-carboxylate
- Packaging100g
- Price$851
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0393288
- Product descriptionMETHYL-5-ISOPROPYL-3,8-DIMETHYLAZULENE-1-CARBOXYLATE 95.00%
- Packaging5MG
- Price$501.39
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD13013942
- Product descriptionMethyl5-isopropyl-3,8-dimethylazulene-1-carboxylate 95+%
- Packaging100g
- Price$564
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM338353
- Product descriptionMethylguaiazulene-3-carboxylate
- Packaging250mg
- Price$55
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 5214AB | Methyl5-isopropyl-3,8-dimethylazulene-1-carboxylate | 100g | $851 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CHM0393288 | METHYL-5-ISOPROPYL-3,8-DIMETHYLAZULENE-1-CARBOXYLATE 95.00% | 5MG | $501.39 | 2021-12-16 | Buy |
| Crysdot | CD13013942 | Methyl5-isopropyl-3,8-dimethylazulene-1-carboxylate 95+% | 100g | $564 | 2021-12-16 | Buy |
| TRC | M338353 | Methylguaiazulene-3-carboxylate | 250mg | $55 | 2021-12-16 | Buy |
Properties
Boiling point :160 °C(Press: 5 Torr)
Density :1.050±0.06 g/cm3(Predicted)
Density :1.050±0.06 g/cm3(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|